DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

0.00 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CRTX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.00

Sector

Healthcare

Industry

Drug Makers

Cornerstone Therapeutics Inc. (CRTX) Description

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response. Website: http://www.crtx.com/

News & Commentary Rss Feed

What's Behind This Biotech's 40% Pop?

Shares of Discovery Labs jumped almost 40% on Friday. Find out what it means for the company as well as drug giant AbbVie and fellow specialty biotech Cornerstone Therapeutics.

Top Insider Trades: PSX YRCW CRTX IDIX

Insider Trading: Marc Lasry Boosts Stake in YRC Worldwide, Baupost Group Increases Idenix Holdings

Plus, a purchase at Cornerstone Therapeutics.

Cornerstone Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript

Osiris Shares Continue to Gain - Analyst Blog

Cornerstone Therapeutics Is Selling Itself Too Cheap

Cornerstone Therapeutics Is Selling Itself Too Short

Zacks #1 Rank Additions for Wednesday - Tale of the Tape

Chiesi Farma, Cornerstone Therapeutics Report Merger Deal for Chiesi to Purchase at $9.50/Share in C

Chiesi Farma, Cornerstone Therapeutics Report Merger Deal for Chiesi to Purchase at $9.50/Share in Cash

Cornerstone Therapeutics: Ignored And Clearly Undervalued

See More CRTX News...

CRTX's Top Competitors

CRTX 0.00 (0.00%)
Current stock: CRTX
AMGN $143.00 (-1.41%)
Current stock: AMGN
GILD $85.26 (0.14%)
Current stock: GILD
BIIB $250.77 (-4.96%)
Current stock: BIIB